Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Seagate Technology Holdings PLC — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Seagate Technology Holdings PLC trades at $778.85 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 7× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Seagate Technology Holdings PLC for 41 Days on average.
| RPRX | STX | |
|---|---|---|
Market Cap | $25.27B | $176.19B |
Volume | 3,671,183 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $63.96 | $1.09K |
52-Week Low | $35.44 | $211.63 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $32.50B | $178.34B |
Dividend Yield | 1.66% | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Seagate Technology (STX) trades at $807.34, up 0.21% with bearish technical signals despite strong fundamental performance. The company reported Q2 2026 EPS of $5.71, beating estimates by 12%, and maintains robust profitability with 26.11% net margins. Recent news highlights competitive pressures as Toshiba plans to expand AI storage production, potentially challenging Seagate's pricing power in the high-capacity drive market.
While analyst consensus remains bullish with a $1,130 price target, near-term risks include increased competition and volatile cash flows. The stock's elevated valuation ratios (P/E 58.1, P/S 15.16) require sustained earnings growth justification, particularly as technical indicators signal caution with resistance at $816.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
